Whalesbook
Solar Industries India expects Rs 14,000 crore revenue in FY27, backed by a record Rs 21,300 crore order book. With the defence division surging, investors are weighing the profit gains against potential execution and raw material risks.
What Happened
Solar Industries India, a major player in industrial explosives and defence manufacturing, has set an ambitious revenue target of approximately Rs 14,000 crore for the fiscal year 2027. This outlook is supported by a record order book of Rs 21,300 crore, which provides the company with significant visibility for future work. The latest financial data for the fourth quarter of fiscal year 2026 shows a strong performance, with revenue jumping 40.9 percent year-on-year to Rs 3,053 crore. Profits saw an even sharper increase of 70 percent, helped by the company's move toward higher-value products in its defence and export businesses.
The Defence Growth Engine
The defence segment has become the most important contributor to the company’s recent growth. In fiscal year 2026 alone, revenue from this division grew by 94 percent to reach Rs 2,634 crore. The company is actively building its position in missile systems, ammunition, and other military products. Key programs like the Pinaka project and the upcoming trials for the Bhargavastra program are central to this strategy. Management expects the defence segment alone to generate over Rs 4,500 crore in revenue in fiscal year 2027, signalling that the business is shifting focus from basic industrial explosives toward specialized defence equipment, which typically offers better profit margins.
Global Expansion Strategy
Beyond domestic defence, the company’s international explosives business is a major growth pillar. Export revenues have climbed consistently, reaching over Rs 3,800 crore in fiscal year 2026. Solar Industries is scaling its manufacturing and distribution network across several countries, including operations in Thailand, Indonesia, Turkey, Kazakhstan, and Australia. The company is also focusing on expansion within Africa. Management has projected another 30 percent growth in export revenues for the coming year, driven by better use of existing manufacturing capacity and deeper penetration into these foreign markets.
Why Margins Matter
The significant jump in net profit indicates that the company is benefitting from operating leverage. This happens when a company grows its revenue faster than its fixed costs, allowing a larger portion of income to flow directly to the bottom line. The move toward specialized, high-margin defence products, rather than just bulk industrial explosives, has played a key role in this profitability improvement. As the product mix shifts toward these higher-value offerings, investors will be watching to see if the company can maintain these improved profit margins.
Risks Investors Should Watch
While the growth outlook is positive, investors should remain aware of specific business risks. The company’s explosives business relies heavily on raw materials like ammonium nitrate, and any volatility in global chemical prices could put pressure on profit margins. Additionally, the defence sector involves long-term contracts with strict execution timelines. Delays in completing government projects or technical challenges in new product trials could impact delivery schedules and cash flow. Furthermore, international operations in regions like Africa and Southeast Asia expose the company to geopolitical risks, currency fluctuations, and regulatory changes in those host countries, which could affect the stability of export earnings.
What Investors Should Track
Moving forward, the primary monitorables for investors include the conversion rate of the Rs 21,300 crore order book into actual revenue. Success in meeting the timelines for major defence programs, such as the 155 mm artillery rounds and the Bhargavastra program, will be crucial. Investors may also track the stability of raw material costs and management’s commentary on whether they can maintain current EBITDA margins as they expand their global footprint. Sustained growth in the international business, despite the risks of operating in multiple foreign markets, will also be a key indicator of the company’s long-term health.